See the original story in Japanese.
Japanese MedTech Startup Allm has secured 5.6 billion yen (over $50.5 million) from investors including Mitsui & Co (TSE:8031) and SOMPO Holdings (TSE:8630), Nikkei reported on Sunday. This round is considered to be a series A extension round while Japanese startup database Initial reports the company’s post-valuation has reached about 32 billion yen (about $300 million).
According to a statement issued by Allm at 11am on Monday, participating investors are:
SOMPO Holdings, Mitsui, Eisai (TSE:4523), Royal Philips (AMS:PHIA), NID (TSE:2349), Cyberdyne (TSE:7779), Financial Agency, Mixi (TSE:2121), Capital Medica, Vector (TSE:6058), SBI Investment, Bonds Investment Group, Mizuho Capital, Asia Africa Investment and Consulting
Royal Philips participated in Allm’s previous series A round as well.
Allm was founded in 2001 by Teppei Sakano as SkillUp Japan. After selling its video distribution platform business, the company entered the medical ICT business in 2015 and rebranded its name into the current state. Since then, the company has rolled out medical device programs in more than a few countries around the world. Their portfolio products include Join (communication app for medical professionals), Enroll (patient recruitment solution), JoinTriage (triage app for emergency transport), Team (comprehensive regional care system promotion solution), and MySOS (life-saving and health app).
Allm will use the funds to focus on research and development of solutions that can contribute to developing countermeasures against COVID-19, not only in Japan but also overseas. The company will team up with Mitsui to help their operating medical institutions in Southeast Asia share information between core hospitals and smaller clinics. It will also develop telemedicine business connecting hospitals in Japan with local doctors in Southeast Asia to support the latter’s medical treatment. It will work with Sompo Holdings to consider creating a system utilizing Allm’s data for insurance and health promotion of nursing home users.